Eva Tornero

739 total citations
15 papers, 254 citations indexed

About

Eva Tornero is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Eva Tornero has authored 15 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Eva Tornero's work include BRCA gene mutations in cancer (9 papers), Genomics and Rare Diseases (6 papers) and Cancer Genomics and Diagnostics (6 papers). Eva Tornero is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Genomics and Rare Diseases (6 papers) and Cancer Genomics and Diagnostics (6 papers). Eva Tornero collaborates with scholars based in Spain, Palestinian Territory and Norway. Eva Tornero's co-authors include Conxi Lázaro, Lídia Feliubadaló, Joan Brunet, Jesús Del Valle, Gabriel Capellá, Ignacio Blanco, Mireia Menéndez, Marta Pineda, Eduard Serra and Sara González and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and PLoS ONE.

In The Last Decade

Eva Tornero

15 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Tornero Spain 8 177 142 93 56 39 15 254
Wera Hofmann Germany 9 240 1.4× 201 1.4× 66 0.7× 57 1.0× 43 1.1× 13 322
Susan L. Slager United States 2 134 0.8× 115 0.8× 59 0.6× 75 1.3× 52 1.3× 3 222
Finn C. Nielsen Denmark 12 157 0.9× 166 1.2× 73 0.8× 46 0.8× 32 0.8× 14 271
Arvīds Irmejs Latvia 10 100 0.6× 101 0.7× 92 1.0× 41 0.7× 65 1.7× 38 215
Ingrid Petroni Ewald Brazil 8 164 0.9× 149 1.0× 79 0.8× 31 0.6× 109 2.8× 12 288
Ester Castellsagué Spain 6 90 0.5× 88 0.6× 99 1.1× 124 2.2× 73 1.9× 7 220
Richard W. Park United States 4 66 0.4× 88 0.6× 80 0.9× 21 0.4× 18 0.5× 5 161
Ewa A. Bergmann United States 3 48 0.3× 98 0.7× 77 0.8× 36 0.6× 40 1.0× 3 177
Bryce A. Seifert United States 7 140 0.8× 90 0.6× 82 0.9× 67 1.2× 40 1.0× 15 229
Hélene Schlecht United Kingdom 7 69 0.4× 100 0.7× 28 0.3× 27 0.5× 60 1.5× 27 199

Countries citing papers authored by Eva Tornero

Since Specialization
Citations

This map shows the geographic impact of Eva Tornero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Tornero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Tornero more than expected).

Fields of papers citing papers by Eva Tornero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Tornero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Tornero. The network helps show where Eva Tornero may publish in the future.

Co-authorship network of co-authors of Eva Tornero

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Tornero. A scholar is included among the top collaborators of Eva Tornero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Tornero. Eva Tornero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rofes, Paula, Mireia Menéndez, Àlex Teulé, et al.. (2025). TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate. Genome Medicine. 17(1). 3–3. 1 indexed citations
2.
Feliubadaló, Lídia, Marta Pineda, Eva Tornero, et al.. (2023). vaRHC: an R package for semi-automation of variant classification in hereditary cancer genes according to ACMG/AMP and gene-specific ClinGen guidelines. Bioinformatics. 39(3). 4 indexed citations
3.
Jové, Maria, Joaquim Bosch‐Barrera, Enric Carcereny, et al.. (2023). Prevalence of pathogenic germline variants in a cohort of patients with early onset non-small cell lung cancer (EOLUNG).. Journal of Clinical Oncology. 41(16_suppl). 10630–10630. 2 indexed citations
4.
Rofes, Paula, Mireia Menéndez, Sara González, et al.. (2020). Improving Genetic Testing in Hereditary Cancer by RNA Analysis. Journal of Molecular Diagnostics. 22(12). 1453–1468. 7 indexed citations
5.
Stradella, Agostina, Jesús Del Valle, Paula Rofes, et al.. (2018). Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?. Journal of Medical Genetics. 56(8). 521–525. 11 indexed citations
6.
Feliubadaló, Lídia, Raúl Tonda, Jean-Rémi Trotta, et al.. (2017). Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer. Scientific Reports. 7(1). 37984–37984. 31 indexed citations
7.
Castellanos, Elisabeth, Bernat Gel, Eva Tornero, et al.. (2017). A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape. Scientific Reports. 7(1). 39348–39348. 39 indexed citations
8.
Quiles, Francisco, Mireia Menéndez, Eva Tornero, et al.. (2016). Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA. Breast Cancer Research and Treatment. 155(2). 253–260. 6 indexed citations
9.
Quiles, Francisco, Àlex Teulé, Lídia Feliubadaló, et al.. (2016). Identification of a founder BRCA1 mutation in the Moroccan population. Clinical Genetics. 90(4). 361–365. 10 indexed citations
10.
Quiles, Francisco, Juana Fernández‐Rodríguez, Roberto Mosca, et al.. (2013). Functional and Structural Analysis of C-Terminal BRCA1 Missense Variants. PLoS ONE. 8(4). e61302–e61302. 16 indexed citations
11.
López‐Doriga, Adriana, Lídia Feliubadaló, Mireia Menéndez, et al.. (2013). ICO Amplicon NGS Data Analysis: A Web Tool for Variant Detection in Common High-Risk Hereditary Cancer Genes Analyzed by Amplicon GS Junior Next-Generation Sequencing. Human Mutation. 35(3). 271–277. 2 indexed citations
12.
Feliubadaló, Lídia, Adriana López‐Doriga, Ester Castellsagué, et al.. (2012). Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. European Journal of Human Genetics. 21(8). 864–870. 82 indexed citations
13.
Menéndez, Mireia, Joan Castellsagué, Eva Pros, et al.. (2011). Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes. Breast Cancer Research and Treatment. 132(3). 979–992. 13 indexed citations
14.
Valle, Jesús Del, Olga Campos, Àngela Velasco, et al.. (2011). Identification of a new complex rearrangement affecting exon 20 of BRCA1. Breast Cancer Research and Treatment. 130(1). 341–344. 2 indexed citations
15.
Valle, Jesús Del, Lídia Feliubadaló, Marga Nadal, et al.. (2009). Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes. Breast Cancer Research and Treatment. 122(3). 733–743. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026